Cardiovascular involvement in autoimmune diseases
- PMID: 25177690
- PMCID: PMC4142566
- DOI: 10.1155/2014/367359
Cardiovascular involvement in autoimmune diseases
Abstract
Autoimmune diseases (AD) represent a broad spectrum of chronic conditions that may afflict specific target organs or multiple systems with a significant burden on quality of life. These conditions have common mechanisms including genetic and epigenetics factors, gender disparity, environmental triggers, pathophysiological abnormalities, and certain subphenotypes. Atherosclerosis (AT) was once considered to be a degenerative disease that was an inevitable consequence of aging. However, research in the last three decades has shown that AT is not degenerative or inevitable. It is an autoimmune-inflammatory disease associated with infectious and inflammatory factors characterized by lipoprotein metabolism alteration that leads to immune system activation with the consequent proliferation of smooth muscle cells, narrowing arteries, and atheroma formation. Both humoral and cellular immune mechanisms have been proposed to participate in the onset and progression of AT. Several risk factors, known as classic risk factors, have been described. Interestingly, the excessive cardiovascular events observed in patients with ADs are not fully explained by these factors. Several novel risk factors contribute to the development of premature vascular damage. In this review, we discuss our current understanding of how traditional and nontraditional risk factors contribute to pathogenesis of CVD in AD.
Figures
![Figure 1](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/4142566/bin/BMRI2014-367359.001.gif)
![Figure 2](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/4142566/bin/BMRI2014-367359.002.gif)
Similar articles
-
Cardiovascular Consequences of Autoimmune Rheumatic Diseases.Curr Vasc Pharmacol. 2020;18(6):566-579. doi: 10.2174/1570161118666200127142936. Curr Vasc Pharmacol. 2020. PMID: 31985379 Review.
-
Stochastic processes in the aetiopathogenesis of scleroderma.Intern Med J. 2012 Mar;42(3):235-42. doi: 10.1111/j.1445-5994.2011.02706.x. Intern Med J. 2012. PMID: 22212090 Review.
-
Systemic autoimmune rheumatic disease prevalence in Canada: updated analyses across 7 provinces.J Rheumatol. 2014 Apr;41(4):673-9. doi: 10.3899/jrheum.130667. Epub 2014 Mar 1. J Rheumatol. 2014. PMID: 24584928
-
Atherosclerotic vascular disease in the autoimmune rheumatologic patient.Curr Atheroscler Rep. 2015 Apr;17(4):497. doi: 10.1007/s11883-015-0497-6. Curr Atheroscler Rep. 2015. PMID: 25721102 Review.
-
Sex-Specific Cardiovascular Comorbidities with Associations in Dermatologic and Rheumatic Disorders.Adv Exp Med Biol. 2018;1065:489-509. doi: 10.1007/978-3-319-77932-4_30. Adv Exp Med Biol. 2018. PMID: 30051403 Review.
Cited by
-
Recent Advances in Biosensors for Diagnosis of Autoimmune Diseases.Sensors (Basel). 2024 Feb 26;24(5):1510. doi: 10.3390/s24051510. Sensors (Basel). 2024. PMID: 38475046 Free PMC article. Review.
-
Cardiovascular events risk in patients with systemic autoimmune diseases: a prognostic systematic review and meta-analysis.Clin Res Cardiol. 2024 Feb;113(2):246-259. doi: 10.1007/s00392-023-02291-4. Epub 2023 Aug 31. Clin Res Cardiol. 2024. PMID: 37650912
-
IFN-γ and androgens disrupt mitochondrial function in murine myocytes.J Pathol. 2023 Jul;260(3):276-288. doi: 10.1002/path.6081. Epub 2023 Apr 27. J Pathol. 2023. PMID: 37185821 Free PMC article.
-
Autoantibodies in Atrial Fibrillation-State of the Art.Int J Mol Sci. 2023 Jan 17;24(3):1852. doi: 10.3390/ijms24031852. Int J Mol Sci. 2023. PMID: 36768174 Free PMC article. Review.
-
Systemic complications of rheumatoid arthritis: Focus on pathogenesis and treatment.Front Immunol. 2022 Dec 22;13:1051082. doi: 10.3389/fimmu.2022.1051082. eCollection 2022. Front Immunol. 2022. PMID: 36618407 Free PMC article. Review.
References
-
- Anaya JM, Castiblanco J, Rojas-Villarraga A, et al. The multiple autoimmune syndromes. A clue for the autoimmune tautology. Clinical Reviews in Allergy and Immunology. 2012;43(3):256–264. - PubMed
-
- Anaya J-M. The diagnosis and clinical significance of polyautoimmunity. Autoimmunity Reviews. 2014;13(4-5):423–426. - PubMed
-
- Hansson GK, Kriszbacher I, Koppán M, Bódis J. Inflammation, atherosclerosis, and coronary artery disease. The New England Journal of Medicine. 2005;352:1685–1695. - PubMed
-
- Blasi C. The autoimmune origin of atherosclerosis. Atherosclerosis. 2008;201(1):17–32. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical